⬡ProtocolPeptide← Home

KNOWLEDGE · PAPERS · UPDATES

Peptides without the noise. Science you can understand.

We read the papers, assess the level of evidence and translate complex mechanisms into plain language. No shortcuts—and no presenting a rat study as a ready-made human therapy.

LATEST ARTICLE

8 MIN READ · PUBMED 30915550

BPC‑157 and soft-tissue repair: what does the paper actually show?

A review of tendon, ligament and muscle research. We explain the proposed mechanisms, the most interesting observations and the central limitation: most evidence comes from animal models.

READ ARTICLE →

Our rule

Source first. Interpretation second.

Every article links to the original publication. We separate laboratory observations from clinically confirmed findings, so readers see not only the promise but also the quality of the evidence behind it.

FULL LIBRARY

Articles on every compound

Choose a name to explore its mechanism, research themes and PubMed literature.

01PUBMED + ANALYSIS

BPC-157

TISSUE RESPONSE

MAINLY PRECLINICAL EVIDENCEREAD →
02PUBMED + ANALYSIS

TB-500

THYMOSIN β4

MAINLY PRECLINICAL EVIDENCEREAD →
03PUBMED + ANALYSIS

GHK-Cu

COPPER COMPLEX

MAINLY PRECLINICAL EVIDENCEREAD →
04PUBMED + ANALYSIS

CJC-1295 Without DAC

GHRH ANALOGUE

MAINLY PRECLINICAL EVIDENCEREAD →
05PUBMED + ANALYSIS

Ipamorelin

GHRELIN RECEPTOR

MAINLY PRECLINICAL EVIDENCEREAD →
06PUBMED + ANALYSIS

KPV + GHK-Cu Blend 60mg

PEPTIDE BLEND

EVIDENCE MAINLY CONCERNS THE COMPONENTSREAD →
07PUBMED + ANALYSIS

Matrixyl 10mg

COSMETIC PEPTIDE

MAINLY PRECLINICAL EVIDENCEREAD →
08PUBMED + ANALYSIS

Chonluten 20mg

BIOREGULATOR

EARLY OR LIMITED SCIENTIFIC EVIDENCEREAD →
09PUBMED + ANALYSIS

Teriparatide 10mg

PTH FRAGMENT

CLINICAL DATA EXIST FOR THE ACTIVE SUBSTANCEREAD →
10PUBMED + ANALYSIS

Klow Blend 80mg

MIESZANKA 4 SKŁADNIKÓW

EVIDENCE MAINLY CONCERNS THE COMPONENTSREAD →
11PUBMED + ANALYSIS

PNC-27

PEPTYD CYKLICZNY

EARLY OR LIMITED SCIENTIFIC EVIDENCEREAD →
12PUBMED + ANALYSIS

Pinealon

BIOREGULATOR

EARLY OR LIMITED SCIENTIFIC EVIDENCEREAD →
13PUBMED + ANALYSIS

PE 22-28 10mg

NEURORESEARCH PEPTIDE

EARLY OR LIMITED SCIENTIFIC EVIDENCEREAD →
14PUBMED + ANALYSIS

Adamax 5mg

NEURORESEARCH PEPTIDE

EARLY OR LIMITED SCIENTIFIC EVIDENCEREAD →
15PUBMED + ANALYSIS

KPV

TRIPEPTYD α-MSH

MAINLY PRECLINICAL EVIDENCEREAD →
16PUBMED + ANALYSIS

VIP

NEUROPEPTIDE

MAINLY PRECLINICAL EVIDENCEREAD →
17PUBMED + ANALYSIS

Tesamorelin + Ipamorelin Blend 18mg

MIESZANKA OSI GH

EVIDENCE MAINLY CONCERNS THE COMPONENTSREAD →
18PUBMED + ANALYSIS

Semax + Selank Blend 20mg

MIESZANKA NEUROPEPTYDÓW

EVIDENCE MAINLY CONCERNS THE COMPONENTSREAD →
19PUBMED + ANALYSIS

Glow Blend 70mg

MIESZANKA 3 SKŁADNIKÓW

EVIDENCE MAINLY CONCERNS THE COMPONENTSREAD →
20PUBMED + ANALYSIS

NAD+

KOENZYM KOMÓRKOWY

MAINLY PRECLINICAL EVIDENCEREAD →
21PUBMED + ANALYSIS

SNAP-8 10mg

COSMETIC PEPTIDE

MAINLY PRECLINICAL EVIDENCEREAD →
22PUBMED + ANALYSIS

ARA-290 10mg

PEPTYD CYTOPROTEKCYJNY

MAINLY PRECLINICAL EVIDENCEREAD →
23PUBMED + ANALYSIS

Cerebrolysin 60mg

KOMPLEKS PEPTYDOWY

LIMITED / SELECTED HUMAN STUDIESREAD →
24PUBMED + ANALYSIS

5-Amino-1MQ

METABOLIC COMPOUND

MAINLY PRECLINICAL EVIDENCEREAD →
25PUBMED + ANALYSIS

Glutathione 1500mg

REDOX TRIPEPTIDE

LIMITED / SELECTED HUMAN STUDIESREAD →
26PUBMED + ANALYSIS

Retatrutide

TRIPLE AGONIST

MAINLY PRECLINICAL EVIDENCEREAD →
27PUBMED + ANALYSIS

LL-37 5mg

PEPTYD OBRONY GOSPODARZA

MAINLY PRECLINICAL EVIDENCEREAD →
28PUBMED + ANALYSIS

FOXO4 10mg

AGEING BIOLOGY

EARLY OR LIMITED SCIENTIFIC EVIDENCEREAD →
29PUBMED + ANALYSIS

MOTS-c

MITOCHONDRIAL PEPTIDE

MAINLY PRECLINICAL EVIDENCEREAD →
30PUBMED + ANALYSIS

Thymosin Alpha-1

THYMIC PEPTIDE

LIMITED / SELECTED HUMAN STUDIESREAD →
31PUBMED + ANALYSIS

Thymalin 10mg

KOMPLEKS GRASICZY

MAINLY PRECLINICAL EVIDENCEREAD →
32PUBMED + ANALYSIS

Kisspeptin-10

REPRODUCTIVE AXIS

MAINLY PRECLINICAL EVIDENCEREAD →
33PUBMED + ANALYSIS

AHK-Cu 100mg

COPPER COMPLEX

MAINLY PRECLINICAL EVIDENCEREAD →
34PUBMED + ANALYSIS

Hexarelin Acetate

SEKRETAGOG GH

MAINLY PRECLINICAL EVIDENCEREAD →
35PUBMED + ANALYSIS

Tesamorelin

GHRH ANALOGUE

CLINICAL DATA EXIST FOR THE ACTIVE SUBSTANCEREAD →
36PUBMED + ANALYSIS

IGF-1 LR3

GROWTH FACTOR

MAINLY PRECLINICAL EVIDENCEREAD →
37PUBMED + ANALYSIS

Follistatin 344 1mg

BIAŁKO WIĄŻĄCE

MAINLY PRECLINICAL EVIDENCEREAD →
38PUBMED + ANALYSIS

AOD-9604

FRAGMENT HGH

MAINLY PRECLINICAL EVIDENCEREAD →
39PUBMED + ANALYSIS

HCG

GONADOTROPINA

CLINICAL DATA EXIST FOR THE ACTIVE SUBSTANCEREAD →
40PUBMED + ANALYSIS

Sermorelin Acetate

FRAGMENT GHRH

LIMITED / SELECTED HUMAN STUDIESREAD →
41PUBMED + ANALYSIS

CJC-1295 With DAC

ANALOG GHRH + DAC

LIMITED / SELECTED HUMAN STUDIESREAD →
42PUBMED + ANALYSIS

CJC-1295 + Ipamorelin Blend

MIESZANKA OSI GH

EVIDENCE MAINLY CONCERNS THE COMPONENTSREAD →
43PUBMED + ANALYSIS

GHRP-6 Acetate

GHRELIN RECEPTOR

LIMITED / SELECTED HUMAN STUDIESREAD →
44PUBMED + ANALYSIS

GHRP-2 Acetate

GHRELIN RECEPTOR

LIMITED / SELECTED HUMAN STUDIESREAD →
45PUBMED + ANALYSIS

SS-31

MITOCHONDRIAL PEPTIDE

MAINLY PRECLINICAL EVIDENCEREAD →
46PUBMED + ANALYSIS

Adipotide

PEPTYD KIERUNKOWY

EARLY OR LIMITED SCIENTIFIC EVIDENCEREAD →
47PUBMED + ANALYSIS

AICAR

METABOLIC COMPOUND

MAINLY PRECLINICAL EVIDENCEREAD →
48PUBMED + ANALYSIS

BPC-157 + TB-500 Blend

PEPTIDE BLEND

EVIDENCE MAINLY CONCERNS THE COMPONENTSREAD →
49PUBMED + ANALYSIS

Oxytocin Acetate

NEUROPEPTYD HORMONALNY

CLINICAL DATA EXIST FOR THE ACTIVE SUBSTANCEREAD →
50PUBMED + ANALYSIS

Triptorelin Acetate 2mg

GnRH ANALOGUE

CLINICAL DATA EXIST FOR THE ACTIVE SUBSTANCEREAD →
51PUBMED + ANALYSIS

DSIP

NEURORESEARCH PEPTIDE

LIMITED / SELECTED HUMAN STUDIESREAD →
52PUBMED + ANALYSIS

Gonadorelin Acetate 2mg

NATURALNY GnRH

CLINICAL DATA EXIST FOR THE ACTIVE SUBSTANCEREAD →
53PUBMED + ANALYSIS

PT-141 10mg

MELANOCORTIN

CLINICAL DATA EXIST FOR THE ACTIVE SUBSTANCEREAD →
54PUBMED + ANALYSIS

MT-2 (Melanotan 2)

MELANOCORTIN

MAINLY PRECLINICAL EVIDENCEREAD →
55PUBMED + ANALYSIS

MT-1 10mg

MELANOCORTIN

CLINICAL DATA EXIST FOR THE ACTIVE SUBSTANCEREAD →
56PUBMED + ANALYSIS

HGH 191AA

PEPTIDE HORMONE

CLINICAL DATA EXIST FOR THE ACTIVE SUBSTANCEREAD →
57PUBMED + ANALYSIS

Semax

NEURORESEARCH PEPTIDE

MAINLY PRECLINICAL EVIDENCEREAD →
58PUBMED + ANALYSIS

Selank

NEURORESEARCH PEPTIDE

MAINLY PRECLINICAL EVIDENCEREAD →
59PUBMED + ANALYSIS

Epitalon

AGEING BIOLOGY

EARLY OR LIMITED SCIENTIFIC EVIDENCEREAD →
60PUBMED + ANALYSIS

Dermorphin

PEPTYD OPIOIDOWY

EARLY OR LIMITED SCIENTIFIC EVIDENCEREAD →

Coming next

01

New peptide publications

02

Mechanisms without jargon

03

Evidence-quality comparisons